DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

CT Homepage

First human undergoes 3D color X-ray scan with CERN technology Shows more details of body's chemical composition

MITA calls for timely exemption process for Section 301 tariffs Calls for exemption of medical imaging technology

Siemens announces first global installation of Biograph Vision PET/CT System yields better temporal resolution and sensitivity than previously reported

Photoacoustic CT tech developed for early stage breast cancer detection Safer, more efficient, and more affordable than mammography, MR and ultrasound: developer

MIT research yields more efficient anatomical 3D printing How 'dithered bitmaps' may increase accessibility of 3D printing in imaging

In PET and SPECT, getting more sensitive and working smarter A look at the newest systems on the market

Trump moves ahead with tariffs, launches trade war with China Applies to medical imaging equipment and parts

Chronos Imaging sells 100th CT X-ray tube in under three months Moving quickly after acquiring the former Dunlee CT tube facility from Philips

Urbana hospital turns to projections to keep kids calm during CT scans Making the diagnostic imaging experience less traumatic for children

Tips for responding efficiently to equipment downtime Experts at AAMI discuss strategies to get back up and running

IBM Watson and Guerbet are pairing up
to create an AI-based solution for
liver cancer detection

Guerbet and IBM Watson to develop AI-based liver diagnostics solution

by John R. Fischer , Staff Reporter
Detecting liver cancer is often a difficult task and one that only occurs when the disease has reached an advanced stage, limiting treatment options and efficiency as well as life expectancy.

IBM Watson Health and Guerbet are hoping to change this through the joint development of Watson Imaging Care Advisor for Liver, an AI-based platform designed to support liver diagnostics in CT and MR imaging.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“We have made progress in cancer care over time, but liver cancer continues to be a global challenge, as the second leading cause of cancer death,” Steve Tolle, VP of strategy and business development at Watson Health Imaging, told HCB News. “Patients at risk for liver cancer often have underlying existing health conditions or liver disease that makes identification of cancerous tumors difficult. The aim is to build imaging analytics tools that help radiologists track changes to the liver in high risk patients to aid in the identification of liver cancer.”

Nearly 50 percent of patients develop metastases in the liver, the most common site for such growths, particularly in cases of digestive cancers. The rate of primary liver cancer cases is especially high in the developing world at 83 percent.

Utilizing AI, the platform will automate detection, staging, tracking, monitoring, therapy prediction and therapy response for primary and secondary liver cancer, enhancing characterization and the chance for earlier identification of metastases to improve chances of recovery.

Development of the French-American solution will be carried out by the IBM research team and leverage prior research innovations alongside Guerbet’s global and clinical expertise in contrast agents and interventional radiology.

It also will be compatible with the most common PACS visualization systems, enabling simple integration directly into the workflows of healthcare professionals.

“There is no existing routine liver cancer screening program as there is for breast, prostate or lung cancer. As a result, liver cancer is often caught at an advanced stage,” said Tolle. “The joint development effort aims to help identify patients that may benefit from focused liver imaging, by taking a ‘second look’ at other abdominal imaging where the liver may be visible in the image.”

Watson Imaging Care Advisor for Liver is one of a number of decision support tools in development to assist radiologists in making diagnostic decisions for their patients with clinical insights derived from IBM Watson image analytics.

Back to HCB News
  Pages: 1

CT Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED